Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Canada Insulin Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 1.45 billion by 2029, growing at a CAGR of 2.67% during the forecast period (2024-2029). According to Diabetes Canada 2021, since the beginning of the COVID-19 pandemic, studies have shown that diabetes ... Read More
-
Indonesia Diabetes Care Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 185.03 million by 2029, growing at a CAGR of 5.73% during the forecast period (2024-2029). The coronavirus disease 2019 (COVID-19) pandemic is a massive worldwide public health disaster caused by the severe ... Read More
-
Indonesia Diabetes Care Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 370.43 million by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029). Inequality in the management of diabetes in Indonesia existed before the COVID-19 pandemic. The gap in health ... Read More
-
Oman Diabetes Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... The market is expected to reach USD 0.34 billion in five years, registering a CAGR of more than 5% during the forecast period. The COVID-19 pandemic has positively impacted the Oman diabetes care equipment market ... Read More
-
Europe Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... to reach USD 675.26 million by 2029, growing at a CAGR of 3.85% during the forecast period (2024-2029). The COVID-19 pandemic has had a significant impact on the market studied. Type-1 diabetes patients have been ... Read More
-
Philippines Diabetes Care Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 319.95 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029). COVID-19 is a novel sickness caused by a SARS-CoV-2 virus strain. Most people infected with the virus ... Read More
-
Vietnam Diabetes Care Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 470.55 million by 2029, growing at a CAGR of 2.10% during the forecast period (2024-2029). Among the nations affected by the COVID-19 epidemic, Vietnam has effectively stopped transmission since the beginning, with ... Read More
-
Australia And New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029). Key Highlights A holistic study of the market studied has been carried out ... Read More
-
Iran Diabetes Care Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 401.90 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029). Inadequate preventive measures interrupted traditional methods of relationship with the patient, medication shortages, disruption of routine diabetic ... Read More
-
Global Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 5.07 billion by 2029, growing at a CAGR of 5.60% during the forecast period (2024-2029). The market is estimated to reach USD 4.5 billion by 2027. The COVID-19 pandemic positively impacted the ... Read More
-
Vietnam Diabetes Care Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... to reach USD 249.97 million by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029). Vietnam has effectively stopped transmission of the COVID-19 outbreak since the outset, with no deaths for months. ... Read More
-
Spain Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... USD 1.02 billion by 2029, growing at a CAGR of 7.41% during the forecast period (2024-2029). In Sapin According to WHO, as of 25 June 2022, a total of 102,258,825 vaccine doses have been administered. ... Read More
-
Oman Diabetes Care Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 75.02 million by 2029, growing at a CAGR of 2.77% during the forecast period (2024-2029). The COVID-19 pandemic positively impacted the Diabetes Care Devices market growth in Oman. Patients with diabetes infected ... Read More
-
Oman Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... USD 292.31 million by 2029, growing at a CAGR of 6.61% during the forecast period (2024-2029). The market is estimated to reach a value of more than USD 258 million by 2027. The COVID-19 pandemic ... Read More
-
Egypt Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... USD 480.70 million by 2029, growing at a CAGR of 3% during the forecast period (2024-2029). The market is estimated to reach a value of more than USD 730 million by 2027. The COVID-19 pandemic ... Read More
-
Iran Diabetes Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... The market is expected to reach 1.3 billion in five years, registering a CAGR of more than 4.3% during the forecast period. Inadequate precautions that disrupt traditional patient relationships, drug shortages, disruptions to routine diabetes ... Read More
-
New Zealand Insulin Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 552.60 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029). After COVID-19 was detected, the risk of developing type 1 diabetes increased. The ... Read More
-
New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 367.23 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029). The likelihood of having type 1 diabetes increased when COVID-19 was discovered. Young pediatric patients ... Read More
-
Japan Insulin Drugs and Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 9.57 billion by 2029, growing at a CAGR of 2.40% during the forecast period (2024-2029). The number of Japanese victims during the COVID-19 pandemic was lower than in ... Read More
-
Egypt Diabetes Care Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... year to USD 442 million by the forecast year, registering a CAGR of 3.36% during the forecast period. The COVID-19 pandemic positively impacted Egypt's diabetes care devices market growth. Patients with diabetes infected with COVID-19 ... Read More
-
Malaysia Insulin Infusion Pump - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 0.92 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029). According to the Agency for Clinical Research (ICR), a research agency affiliated with the National Institutes of ... Read More
-
Middle East and Africa Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... million in 2024, and is expected to reach USD 50.85 million by 2029, growing at a CAGR of 4.80% during the forecast period (2024-2029). The COVID-19 pandemic positively impacted the growth of the insulin infusion ... Read More
-
South Korea Diabetes Care Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... is expected to reach USD 529.86 million by 2029, growing at a CAGR of 3% during the forecast period (2024-2029). The COVID-19 pandemic has substantially impacted the diabetes care devices market. The prevalence of diabetes ... Read More
-
South Korea Insulin Infusion Pump - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 21.88 million by 2029, growing at a CAGR of 4.02% during the forecast period (2024-2029). Diabetes patients are more prone to experience complications if they become infected with a virus. ... Read More
-
South Korea Insulin Drugs And Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... of 1.5% and reach a value of about USD 795 million over the forecast period. One of the most significant risk factors for severe COVID-19 was diabetes mellitus. This risk is believed to be influenced ... Read More
Research Assistance
